Home › Funds › F/m Investments LLC › LGND

F/m Investments LLC position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

F/m Investments LLC reported holding 40,769 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.7M, representing 0.38% of its reported portfolio and ranking #43 among its reported holdings. F/m Investments LLC has disclosed LGND holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)40.77K sh
Reported value held$12.73M
Portfolio Weight0.38%
First reportedQ2 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How F/m Investments LLC's LGND position evolved

F/m Investments LLC first disclosed a stake in LGND in Q2 2024 at 134,710 shares (US$11.4M). The position peaked in Q3 2024 at 134,299 shares, worth US$13.4M. Across 10 filings, F/m Investments LLC increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 40,769 shares valued at US$12.7M — an increase of 38,916 shares quarter over quarter.. Notable position changes include a 61% trim in Q4 2024 (shares fell 2% over the following quarter), a 96% trim in Q1 2026 (shares rose 58% over the following quarter), a 2100% increase in Q3 2026 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 134.71K $11.35M New
Q3 2024 134.30K $13.44M Hold
Q4 2024 52.88K $5.67M Reduce
Q1 2025 52.24K $5.49M Reduce
Q2 2025 52.51K $5.97M Add
Q3 2025 51.48K $9.12M Reduce
Q4 2025 46.13K $8.72M Reduce
Q1 2026 2.00K $398.68K Reduce
Q2 2026 1.85K $583.85K Reduce
Q3 2026 40.77K $12.73M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 52 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has F/m Investments LLC held LGND?

F/m Investments LLC has disclosed LGND holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is F/m Investments LLC's current position in LGND?

As of Q3 2026, F/m Investments LLC holds 40.77K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $12.73M, representing 0.38% of its reported portfolio and ranking #43.

Has F/m Investments LLC been buying or selling LGND?

In the latest 13F filing (Q3 2026), F/m Investments LLC increased its position in LGND. The position peaked in Q3 2024 at 134.30K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.